Please enable Javascript
Rebecca Araujo
Articles by Rebecca Araujo
Increased Psychiatric Burden in Patients with Juvenile Idiopathic Arthritis
Rebecca Araujo
Rheumatology
|
June 2, 2023
A study reported an increased psychiatric morbidity burden in patients with juvenile idiopathic arthritis.
Read More
Coronary Artery Calcification Severity Is Associated with Rate of Adverse PCI Outcomes
Rebecca Araujo
Interventional Cardiology
|
November 19, 2021
A pooled analysis of randomized trials found that moderate to severe coronary artery calcification (CAC) is associated ...
Read More
In PE, Improved Survival Found for Surgery vs. Catheter-Based Interventions
Rebecca Araujo
Interventional Cardiology
|
November 3, 2021
Using catheter-based interventions (CBI) for acute pulmonary embolism (PE) is associated with reduced PE recurrence when ...
Read More
Telemedicine in Oncology: RT Patients Report High Satisfaction
Rebecca Araujo
Telemedicine
|
October 19, 2021
Patients receiving radiotherapy reported high satisfaction with telemedicine in their oncology consultations, according ...
Read More
Impact of Sleep Disorders and Fatigue in Children with Cancer
Rebecca Araujo
Sleep Disorders
|
September 15, 2021
A study of children with cancer identified an association between physical activity, fatigue, and sleep and quality of ...
Read More
Coagulation Factor Activity May Be Linked to PAD Complications
Rebecca Araujo
Atherosclerotic Disease
|
August 10, 2021
Patients with atherosclerotic peripheral arterial disease (PAD) have marked increases in coagulability, defined as ...
Read More
Empagliflozin Shows HF Benefit Regardless of Baseline Circulating Troponin Levels
Rebecca Araujo
Heart Failure
|
June 3, 2021
Treatment with empagliflozin was beneficial for patients with heart failure (HF), regardless of circulating troponin ...
Read More
Sleep Duration Linked to Risk of Cardiovascular Events
Rebecca Araujo
ACC 2021 Conference
|
May 6, 2021
Sleeping too much or too little was found to elevate risk of cardiovascular events, according to research that will be ...
Read More
Dr. Martin: Improving Survival Rates in High-Risk Multiple Myeloma
Rebecca Araujo
Hematology & Oncology
|
April 29, 2021
Docwire News spoke with Thomas G. Martin, MD, Professor of Medicine and Associate Director of the Myeloma Program at the ...
View More
Defining High-Risk Multiple Myeloma, with Dr. Martin
Rebecca Araujo
Hematology & Oncology
|
April 28, 2021
Docwire News spoke with Thomas G. Martin, MD, Professor of Medicine and Associate Director of the Myeloma Program at the ...
View More
Dr. Callander: Ocular Toxicity After Multiple Myeloma Treatment
Rebecca Araujo
Hematology & Oncology
|
March 31, 2021
DocWire News spoke with Natalie Callander, MD, professor and director of the Myeloma Clinical Program at the University ...
View More
Dr. Callander: BCMA CAR T Cell Therapy for Relapsed/Refractory MM
Rebecca Araujo
Hematology & Oncology
|
March 30, 2021
DocWire News sat down with Natalie Callander, MD, professor and director of the Myeloma Clinical Program at the ...
View More
FDA Approval of Melflufen for Relapsed/Refractory MM, with Dr. Callander
Rebecca Araujo
Hematology & Oncology
|
March 29, 2021
DocWire News sat down with Natalie Callander, MD, professor and director of the Myeloma Clinical Program at the ...
View More
Hyperkalemia Linked to CV Events in Patients with Heart Failure
Rebecca Araujo
Hyperkalemia
|
December 28, 2020
In a large, real-world population study of patients with heart failure (HF), hyperkalemia was common and linked to ...
Read More
Older Women With Sedentary Lifestyles Face Increased Heart Failure Risk
Rebecca Araujo
Heart Failure
|
November 30, 2020
Older women who spend more time in sedentary behaviors, such as sitting or lying down, are at an increased risk of heart ...
Read More
Population Screening for Hereditary Cancers Is Beneficial for Young Women
Rebecca Araujo
Ovarian Cancer
|
November 16, 2020
According to a new study, population-wide screening for genetic variants linked to hereditary breast and ovarian cancer ...
Read More
Low HDL Cholesterol is a Biomarker for Rare Plasma Cell Disorder
Rebecca Araujo
Lipid Management
|
November 2, 2020
Having low levels of high-density lipoprotein cholesterol (HDLC) has been identified as a novel serum biomarker for ...
Read More